Our Future Health: a unique global resource for discovery and translational research.
Cook MB. et al, (2025), Nat Med
"Target Trial Emulation" for Observational Studies - Potential and Pitfalls.
Hubbard RA. et al, (2024), N Engl J Med, 391, 1975 - 1977
Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Kentistou KA. et al, (2024), Nat Genet
Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Kentistou KA. et al, (2024), Nat Genet
Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
Collister JA. et al, (2024), Cancer Epidemiol Biomarkers Prev, 33, 812 - 820
Incorporating polygenic risk into the Leicester Risk Assessment score for 10-year risk prediction of type 2 diabetes.
Liu X. et al, (2024), Diabetes Metab Syndr, 18
Assessing the importance of primary care diagnoses in the UK Biobank.
Clifton L. et al, (2024), Eur J Epidemiol
Where Medical Statistics Meets Artificial Intelligence. Reply.
Hunter DJ. and Holmes C., (2023), N Engl J Med, 389, 2403 - 2404
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study.
Watts EL. et al, (2023), Br J Cancer
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Wang A. et al, (2023), Nat Genet, 55, 2065 - 2074
Where Medical Statistics Meets Artificial Intelligence.
Hunter DJ. and Holmes C., (2023), N Engl J Med, 389, 1211 - 1219
Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank.
Yeh T-S. et al, (2023), Alzheimers Res Ther, 15
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Middha P. et al, (2023), Breast Cancer Res, 25
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J. et al, (2023), Diabetologia, 66, 1481 - 1500
At Breaking Point or Already Broken? The National Health Service in the United Kingdom.
Hunter DJ., (2023), N Engl J Med, 389, 100 - 103
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Darst BF. et al, (2023), Am J Hum Genet, 110, 1200 - 1206
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.
Koutros S. et al, (2023), Eur Urol, 84, 127 - 137
Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Kentistou KA. et al, (2023), medRxiv